Ursula Theuretzbacher

Author

Also Known As

Adriano Cristinziano, Anders Kristoffersson, Theuretzbacher, Ursula, U THEURETZBACHER, U. Theuretzbacher, Ursula Theuretzbacher

108

Publications

14.2K

Citations

H-Index

Concepts

All Affiliations

Uppsala University Tel Aviv University Rabin Medical Center Erasmus University Rotterdam Rambam Health Care Campus

About

Ursula Theuretzbacher is an author at Uppsala University specializing in medicine, antimicrobial resistance, and antibiotics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	14	7.6K
2	Health Sciences	6	7	6.7K
3	Law	1	1	15
4	Public Health	1	2	78
5	Economics	1	1	15

Ursula Theuretzbacher

Publications

Citations

H-Index

Page 1

	Year	Citations
Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis Evelina Tacconelli, Elena Carrara, Alessia Savoldi, The Lancet Infectious Diseases Bacterial ResistanceAntimicrobial Drug DiscoveryAntimicrobial SusceptibilityHealth SciencesAntibiotics	2017	5.8K
Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial Mical Paul, George L. Daikos, Emanuele Durante‐Mangoni, The Lancet Infectious Diseases Severe InfectionsHealth SciencesAntibioticsAntimicrobial SusceptibilityCarbapenem-resistant Gram-negative Bacteria	2018	593
Pharmacokinetic/Pharmacodynamic Profile of Voriconazole Ursula Theuretzbacher, Franziska Ihle, Hartmut Derendorf Clinical Pharmacokinetics Pharmacological StudyPharmacodynamicsMedicinePharmacokinetic/pharmacodynamic ProfilePharmacotherapy	2006	464
Framework for optimisation of the clinical use of colistin and polymyxin B: the Prato polymyxin consensus Roger L. Nation, Jian Li, Otto Cars, The Lancet Infectious Diseases Microbial ToxinGastroenterologyMicrobiologyInfection ControlUlcerative Colitis	2014	331
Effect of 5-Day Nitrofurantoin vs Single-Dose Fosfomycin on Clinical Resolution of Uncomplicated Lower Urinary Tract Infection in Women Angela Huttner, Anna Kowalczyk, ‪Adi Turjeman‬‏, JAMA	2018	200
Antibiotic research and development: business as usual? Stephan Harbarth, Ursula Theuretzbacher, Judith Hackett, Journal of Antimicrobial Chemotherapy	2015	83
Colistin plus meropenem for carbapenem-resistant Gram-negative infections: in vitro synergism is not associated with better clinical outcomes Amir Nutman, Jonathan Lellouche, Elizabeth Temkin, Clinical Microbiology and Infection Antimicrobial SusceptibilityHealth SciencesAntibioticsVitro SynergismBetter Clinical Outcomes	2020	75
Multicentre open-label randomised controlled trial to compare colistin alone with colistin plus meropenem for the treatment of severe infections caused by carbapenem-resistant Gram-negative infections (AIDA): a study protocol Yaakov Dickstein, Leonard Leibovici, Dafna Yahav, BMJ Open	2016	45
Forgotten antibiotics: a follow-up inventory study in Europe, the USA, Canada and Australia C. Pulcini, Simone Mohrs, Bojana Beović, International Journal of Antimicrobial Agents Preventive MedicineAntibioticsAntimicrobial StewardshipHealthcare-associated InfectionInternational Health	2016	39
Nature's clarion call of antibacterial resistance: are we listening? Ursula Theuretzbacher, Jeffery H Toney PubMed Antimicrobial ChemotherapyAntibiotic ResistanceDrug ResistanceClarion CallPharmaceutical Companies	2006	36

Page 1